Who owns Amicus Therapeutics?

Key details on Amicus Therapeutics (Ticker: FOLD)

Who owns Amicus Therapeutics?

Is FOLD a good stock to own? Find out who bought Amicus Therapeutics, who sold Amicus Therapeutics (FOLD) stock, and who holds a large position in Amicus Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Redmile 8.50M $17.59M March 31, 2014
NEA Management Company 5.65M $11.70M March 31, 2014
Palo Alto Investors 3.97M $8.22M March 31, 2014
RS INVESTMENT MANAGEMENT 2.82M $5.83M March 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.46M $5.08M March 31, 2014
HealthCor Management 2.28M $6.11M Dec. 31, 2012
Bridger Management 1.71M $9.01M March 31, 2012
Dr. Jeffrey R. Jay, M.D 1.64M $5.64M Dec. 31, 2011
Wellington Management Company 1.42M $3.31M June 30, 2013
Vanguard 1.23M $2.56M March 31, 2014
Perceptive Advisors 966300 $2.00M March 31, 2014
BlackRock Fund Advisors 854639 $1.77M March 31, 2014
Austin W. Marxe and David M. Greenhouse 821466 $4.27M Sept. 30, 2012
D. E. Shaw & Co 660790 $1.37M March 31, 2014
Sound Energy Partners 595200 $1.23M March 31, 2014
Technical Financial Services 586651 $1.38M Dec. 31, 2013
FMR 562204 $1.16M March 31, 2014
Samlyn Capital 550000 $3.02M June 30, 2012
Driehaus Capital Management 513523 $1.63M March 31, 2013
Balyasny Asset Management 512284 $1.20M Dec. 31, 2013
Baker Bros. Advisors 481697 $997112 March 31, 2014
Bailard 468000 $1.48M March 31, 2013
PUTNAM INVESTMENTS 452200 $0 March 31, 2014
STATE STREET CORPORATION 434456 $899323 March 31, 2014
NORTHERN TRUST 401450 $831001 March 31, 2014
Millennium Management 400000 $932000 June 30, 2013
SMITH ASSET MANAGEMENT 368640 $1.23M June 30, 2014
SUSQUEHANNA INTERNATIONAL 358563 $842623 Dec. 31, 2013
Royce & Associates 355700 $835895 Dec. 31, 2013
GOLDMAN SACHS 331769 $889140 Dec. 31, 2012
BlackRock Institutional Trust Company, N.A. 315974 $733059 Sept. 30, 2013

Who sold Amicus Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Global Endowment Management Dec. 31, 2010 668448 $3.08M